Differential expression, function and prognostic value of miR-17–92 cluster in ER-positive and triple-negative breast cancer
Recent evidence has shown that the miR-17–92 cluster can function either as oncogene or tumor suppressor in human cancers. The function of miR-17–92 in subtypes of breast cancer remains largely unknown. The expression of miR-17–92 is elevated in triple negative breast cancer (TNBC) but reduced in es...
Main Authors: | Muhammad Mosaraf Hossain, Afrin Sultana, David Barua, Md Nahidul Islam, Ananya Gupta, Sanjeev Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Cancer Treatment and Research Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468294220300599 |
Similar Items
-
The miR-17-92 cluster: Yin and Yang in human cancers
by: Wenyuan Zhao, et al.
Published: (2022-01-01) -
Downregulation of miR-17-92 Cluster by PERK Fine-Tunes Unfolded Protein Response Mediated Apoptosis
by: Danielle E. Read, et al.
Published: (2021-01-01) -
RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity
by: David Barua, et al.
Published: (2023-03-01) -
Insights into regulation of the miR-17-92 cluster of miRNAs in cancer
by: Cesar Seigi Fuziwara, et al.
Published: (2015-09-01) -
Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
by: Line Moi, et al.
Published: (2019-10-01)